Chargement en cours...

Protection from Genital Herpes Disease, Seroconversion, and Latent Infection in a Non-lethal Murine Genital Infection Model by Immunization with an HSV-2 Replication-Defective Mutant Virus

Viral vaccines have traditionally protected against disease, but for viruses that establish latent infection, it is desirable for the vaccine to reduce infection to reduce latent infection and reactivation. While seroconversion has been used in clinical trials of herpes simplex virus (HSV) vaccines...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Virology
Auteurs principaux: Diaz, Fernando M., Knipe, David M.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744556/
https://ncbi.nlm.nih.gov/pubmed/26609935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2015.10.033
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!